Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Conjupro Biotherapeutics, Inc.
Xencor, Inc.
Atavistik Bio, Inc
Mayo Clinic
Eli Lilly and Company
WestVac Biopharma Co., Ltd.
Whitehawk Therapeutics, Inc.
Dana-Farber Cancer Institute
NiKang Therapeutics, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
Alterome Therapeutics, Inc.
Boehringer Ingelheim
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
AstraZeneca
BeOne Medicines
Daewoong Pharmaceutical Co. LTD.
Dana-Farber Cancer Institute
Primelink BioTherapeitics(ShenZhen) Limited
Whitehawk Therapeutics, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
Accent Therapeutics
Pfizer
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
TORL Biotherapeutics, LLC
Clasp Therapeutics, Inc.
Normunity AccelCo, Inc.
BioNTech SE
Eli Lilly and Company
NiKang Therapeutics, Inc.
AstraZeneca
Verismo Therapeutics
University of Alabama at Birmingham
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Avacta Life Sciences Ltd
Theolytics Limited
Regeneron Pharmaceuticals